Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d22b649c54d79d7c1eabf23085b14a3e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2720-12351 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2720-12322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2720-12334 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-0216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-08 |
filingDate |
2000-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_558796c1b83f235a49e30453a255f3c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a28d849832783da30971a37fd29ce409 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1370973583553c614e205f27b8b9af3d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18b65d8e1913d538e3a6cc5dff240609 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b797bd6b2d38f432b29ef44bace95faa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a24b2b5051c9bb475b9b98a63cefb7d |
publicationDate |
2006-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1676586-A1 |
titleOfInvention |
Method of separating rotavirus variants and live attenuated rotavirus vaccine |
abstract |
The invention provides an attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7. The invention particularly provides a rotavirus population designated as P43. The invention further provides a novel formulation for a rotavirus vaccine which is in the form of a quick dissolving tablet for immediate dissolution when placed on the tongue. |
priorityDate |
1999-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |